Brief: Verrica Pharmaceuticals Q3 adjusted EPS USD -0.32
09/11/2023 12:40
Nov 9 (Reuters) - Verrica Pharmaceuticals Q3 net income USD -24.802 million. * Q3 collaboration revenue USD 2.792 million * Q3 income from operations USD -23.917 million * Q3 adjusted net income USD -14.8 million * Q3 adjusted EPS USD -0.32
Recent news on Verrica Pharmaceuticals
See all newsVerrica Pharmaceuticals Inc reports results for the quarter ended June 30 - Earnings Summary
Verrica Pharma reports wider-than-expected Q2 adj loss per share
Verrica Pharmaceuticals Inc expected to post a loss of 38 cents a share - Earnings Preview
Verrica Pharmaceuticals Q1 revenue rises on YCANTH demand
Brief: Verrica Pharmaceuticals Announces Upcoming Presentation Of Phase 2 Data